These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1281381)

  • 1. Effects of protease inhibitors in experimental septic shock.
    Siebeck M; Spannagl M; Hoffmann H; Fink E
    Agents Actions Suppl; 1992; 38 ( Pt 3)():421-7. PubMed ID: 1281381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of the combination of two proteinase inhibitors in endotoxin shock of the pig.
    Siebeck M; Hoffmann H; Weipert J; Spannagl M
    Prog Clin Biol Res; 1989; 308():937-43. PubMed ID: 2780741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the elastase inhibitor eglin C in porcine endotoxin shock.
    Siebeck M; Hoffmann H; Weipert J; Fritz H
    Circ Shock; 1992 Mar; 36(3):174-9. PubMed ID: 1351797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation.
    Renesto P; Ferrer-Lopez P; Chignard M
    Lab Invest; 1990 Apr; 62(4):409-16. PubMed ID: 2159081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A brief review of the biochemistry and pharmacology of Eglin c, an elastase inhibitor.
    Braun NJ; Schnebli HP
    Eur J Respir Dis Suppl; 1986; 146():541-7. PubMed ID: 3536558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed treatment with desulfato-hirudin prevents fibrin formation in lipopolysaccharide-induced shock.
    Siebeck M; Spannagl M; Bichler J; Hoffmann H; Gippner-Steppert C; Jochum M
    Thromb Res; 1997 Dec; 88(6):473-80. PubMed ID: 9610958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte neutral proteinase inhibitor of the pig: modification by eglin C and superoxide dismutase of the response to shock.
    Siebeck M; Hoffmann H; Geiger R; Schweiberer L
    Prog Clin Biol Res; 1989; 308():945-51. PubMed ID: 2675078
    [No Abstract]   [Full Text] [Related]  

  • 8. Reasons for the ineffectiveness of eglin C to ameliorate endotoxin shock in sheep.
    Junger WG; Lieners C; Redl H; Schlag G
    Prog Clin Biol Res; 1989; 308():953-7. PubMed ID: 2780742
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of aprotinin, a protease inhibitor, on porcine E. coli shock. Studies on coagulation, fibrinolytic and hemodynamic response.
    Svartholm E; Haglund U; Ljungberg J; Hedner U
    Acta Chir Scand; 1989; 155(1):7-13. PubMed ID: 2467477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of recombinant hirudin, a specific inhibitor of thrombin, on endotoxin-induced intravascular coagulation and acute lung injury in pigs.
    Hoffmann H; Siebeck M; Spannagl M; Weis M; Geiger R; Jochum M; Fritz H
    Am Rev Respir Dis; 1990 Oct; 142(4):782-8. PubMed ID: 2221583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
    Baudo F; de Cataldo F
    Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the value of giving a combination of drugs for the treatment of endotoxaemia in pigs.
    Naess F; Roeise O; Stadaas JO; Aasen AO
    Eur J Surg; 1992 Feb; 158(2):95-103. PubMed ID: 1350222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of plasma kallikrein with aprotinin in porcine endotoxin shock.
    Siebeck M; Fink E; Weipert J; Jochum M; Fritz H; Spannagl M; Kroworsch P; Shimamoto K; Schweiberer L
    J Trauma; 1993 Feb; 34(2):193-8. PubMed ID: 7681484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of aprotinin on activated protein C-mediated downregulation of endogenous thrombin generation.
    Tanaka KA; Szlam F; Levy JH
    Br J Haematol; 2006 Jul; 134(1):77-82. PubMed ID: 16803571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental studies on the effect of prophylactic proteinase inhibitor therapy on endotoxin shock.
    Sumida S
    Adv Exp Med Biol; 1979; 120B():395-401. PubMed ID: 390988
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of a combined drug regimen on tumour necrosis factor and plasma kallikrein activity in experimental endotoxaemia.
    Naess F; Waage A; Roeise O; Stadaas JO; Aasen AO
    Eur J Surg; 1994 Feb; 160(2):77-86. PubMed ID: 8193212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic consequences of multitherapy pretreatment in experimental endotoxemia.
    Pillgram-Larsen J; Ruud TE; Stadaas JO; Aasen AO
    Prog Clin Biol Res; 1987; 236A():227-34. PubMed ID: 3303044
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant antitrypsin Pittsburgh undergoes proteolytic cleavage during E. coli sepsis and fails to prevent the associated coagulopathy in a primate model.
    Harper PL; Taylor FB; DeLa Cadena RA; Courtney M; Colman RW; Carrell RW
    Thromb Haemost; 1998 Nov; 80(5):816-21. PubMed ID: 9843177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aprotinin in cardiac surgery.
    Sodha NR; Boodhwani M; Bianchi C; Ramlawi B; Sellke FW
    Expert Rev Cardiovasc Ther; 2006 Mar; 4(2):151-60. PubMed ID: 16509811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of protease inhibitors and an antioxidant for treatment of sulfur mustard-induced toxic lung injury.
    Anderson DR; Taylor SL; Fetterer DP; Holmes WW
    Toxicology; 2009 Sep; 263(1):41-6. PubMed ID: 18852015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.